EUVIMEDDescoperă EUVIMED
Open access · CC BY-NC-ND 4.0

Single-Cell Profiling of Apoptotic Resistance in Patient-Derived Xenografts and Primary Circulating Tumor Cells Using TetherChip

Darin E Gilchrist iD, Keyata N Thompson, Julia A Ju iD, David A Annis iD, Makenzy L Mull, Destiny O Omili, Jessica L Cornell, Nevenka Dimitrova, Haley Hendrick, Min Yu, John C Schmitz, Taofeek K Owonikoko and 2 more

ACS Applied Materials & Interfaces · 2026

DOI: 10.1021/acsami.6c03498 ↗

At a glance

Journal article in ACS Applied Materials & Interfaces, 2026. Written by Darin E Gilchrist and 13 co-authors. Institution: Marlene and Stewart Greenebaum NCI Comprehensive Cancer Center, University of Maryland School of Medicine, 655 W. Baltimore St., Baltimore, Maryland2…. Major MEDLINE topics: Neoplastic Cells, Circulating, Single-Cell Analysis, Apoptosis. 53 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NCI NIH HHS, National Cancer Institute.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Circulating tumor cells (CTCs) must escape the primary tumor and spread to distant organs through harsh, nonadherent blood, and lymphatic microenvironments, where over 99% perish. Some CTCs survive by resisting extracellular matrix (ECM) detachment-induced apoptosis (anoikis). CTC enumeration has already been directly linked to poor patient outcomes. Single-cell profiling of the anoikis resistance phenotype of CTCs could improve our diagnostic capabilities; however, there remain technical limitations to isolating and characterizing live, nonadherent tumor cells. To address this gap in knowledge, our group developed a cell tethering nanosurface, TetherChip, that enables high-resolution microscopy over extended time periods of live, nonadherent single cells within minutes to hours of detachment and/or isolation. This study leveraged optically clear microfluidic slides with the TetherChip nanosurface to develop an anoikis resistance profiling assay that combines real-time cell tracking with caspase activation to assess apoptotic resistance in nonadherent conditions. This assay was first optimized in cultured breast and lung cancer cell lines and subsequently extended to clinically applicable patient-derived xenograft (PDX) and patient CTC samples as a proof-of-concept for translational feasibility. This platform integrated AI-assisted analysis techniques and implemented fluorescent multiplexing to ultimately enable an efficient tumor-specific, single-cell analysis for TetherChip anoikis resistance profiling of live, nonadherent tumor cells.

Subjects

MeSH terms (MEDLINE)

Neoplastic Cells, CirculatingSingle-Cell AnalysisApoptosisHumansAnimalsCell Line, TumorAnoikisMiceFemaleLab-On-A-Chip Devices

Author keywords

TetherChipanoikisapoptosiscancercirculating tumor cellsmicrofluidic platformnonadherent

Authors and institutions

  • Marlene and Stewart Greenebaum NCI Comprehensive Cancer Center, University of Maryland School of Medicine, 655 W. Baltimore St., Baltimore, Maryland21201, United States.
  • Medical Scientist Training Program, University of Maryland School of Medicine, 20 Penn St., RM S359, Baltimore, Maryland21201, United States.
  • Graduate Program in Molecular Medicine, University of Maryland School of Medicine, 800 W. Baltimore St., Baltimore, Maryland21201, United States.
  • Department of Pharmacology & Physiology, University of Maryland School of Medicine, 655 W. Baltimore St., Baltimore, Maryland21201, United States.
  • Graduate Program in Epidemiology and Human Genetics, University of Maryland, 660 W. Redwood St., Rm 213, Baltimore, Maryland21201, United States.
  • Department of Pathology, University of Colorado Denver - Anschutz Medical Campus, 12631 East 17th Avenue, 2nd Floor, Aurora, Colorado80045, United States.

ORCID profiles: Darin E Gilchrist, Julia A Ju, David A Annis

Funding

  • NCI NIH HHS
  • National Cancer Institute

Cite

APA

Gilchrist, D. E., Thompson, K. N., Ju, J. A., Annis, D. A., Mull, M. L., Omili, D. O., Cornell, J. L., Dimitrova, N., Hendrick, H., Yu, M., Schmitz, J. C., Owonikoko, T. K., Vitolo, M. I., & Martin, S. S. (2026). Single-Cell Profiling of Apoptotic Resistance in Patient-Derived Xenografts and Primary Circulating Tumor Cells Using TetherChip. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c03498

Vancouver

Gilchrist DE, Thompson KN, Ju JA, Annis DA, Mull ML, Omili DO, et al. Single-Cell Profiling of Apoptotic Resistance in Patient-Derived Xenografts and Primary Circulating Tumor Cells Using TetherChip. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c03498

BibTeX
@article{Gilchrist2026,
  author = {Gilchrist, Darin E and Thompson, Keyata N and Ju, Julia A and Annis, David A and Mull, Makenzy L and Omili, Destiny O and Cornell, Jessica L and Dimitrova, Nevenka and Hendrick, Haley and Yu, Min and Schmitz, John C and Owonikoko, Taofeek K and Vitolo, Michele I and Martin, Stuart S},
  title = {Single-Cell Profiling of Apoptotic Resistance in Patient-Derived Xenografts and Primary Circulating Tumor Cells Using TetherChip},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  doi = {10.1021/acsami.6c03498}
}
Start for free →